- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 678.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 669.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 662.5M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$243.66K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$601.38K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $633 |
| Cash And Equivalents restated | Q1 2026 · Dec 31, 2025 | $1.8K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$30.27M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$30.15M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$20.51M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$19.81M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $31.49M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $31.59M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $36.85M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $37.17M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $929.55K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.31M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.58M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.02M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$382.02K |
| Net Income | Q1 2026 · Dec 31, 2025 | −$10.44M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$690.59K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$682.34K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$677.59K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$409.45K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$502.61K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.04M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $837.93K |
| Revenue | Q1 2026 · Mar 31, 2026 | $627.46K |
| Revenue | Q1 2026 · Mar 31, 2025 | $335.32K |